Dollars for Doctors

How Industry Money Reaches Physicians

ProPublica is tracking the financial ties between doctors and medical companies.

Med Schools Flunk at Keeping Faculty Off Pharma Speaking Circuit

Top U.S. medical schools and teaching hospitals are failing to adequately enforce policies that prohibit or restrict faculty physicians from being paid by drug companies to give promotional speeches about their products.

In Minnesota, Drug Company Reports of Payments to Doctors Arrive Riddled With Mistakes

A new federal plan will require drug and medical device companies to report all payments to U.S. physicians in 2013. The danger? As Minnesota discovered, some information submitted may not be accurate.

Massachusetts Posts Pharma Payments to Health Providers

This week, Massachusetts became the first state to post an online database of payments from drug and medical device companies to the state’s health care providers.

Dollars for Docs: Who’s On Pharma’s Top-Paid List?

A review of the highest-earning physicians in ProPublica’s Dollars for Docs database offers insight into why some medical professionals are drawn to the lucrative sideline of public speaking to promote favored drugs.

Doctors on Pharma Payroll: What Our Partners Found

While it’s not illegal for doctors to promote prescription drugs and accept payments from drug companies, such arrangements do raise ethical questions that some institutions have found concerning enough to try to limit.

Editor's Note: Dollars for Docs

The stories ProPublica is publishing today on the drug industry are part of a broader effort to expand the possibilities of collaborative journalism.

Lawsuits Say Pharma Illegally Paid Doctors to Push Their Drugs

Pharma companies are being accused in lawsuits of paying doctors to push off-label uses of their drugs or financially rewarding doctors for prescribing their brand-name medications.

Consumer Reports: Most Patients Worry About Pharma Payments to Doctors

A Consumer Reports survey has found that patients say they would be concerned about the quality of care they receive from a doctor who is paid to promote a drug. And they said they want to know about such payments.

Follow ProPublica

Latest Stories from ProPublica